TS-062232 — The Need The current demand in the market is for a safe and effective SARS-CoV-2 vaccine that can induce both antibody and T cell responses. The traditional understanding of antibody-based immunity is incomplete, as virus-infected cells are eliminated with the help of T cells. To combat SARS-CoV-2 …